PA Files Lawsuit Against Pharmaceuticals, Benefit Mangers over Inflated Insulin Prices

Pennsylvania sues pharma companies for allegedly colluding to manipulate insulin prices

Attorney General Dave Sunday is seeking restitution for diabetic Pennsylvanians harmed by inflated insulin prices in a new lawsuit against drug manufacturers like Eli Lilly and pharmacy benefit managers like Caremark and OptumRx.

PA files lawsuit against pharmaceuticals, benefit mangers over inflated insulin prices

PENNSYLVANIA (WTAJ) — A lawsuit has been filed against several pharmaceutical companies and pharmacy benefit managers (PBMs) regarding collusion to manipulate insulin price markets. The Office of Attorney General's Antitrust Section filed the complaint this week alleging violations of Pennsylvania's Unfair Trade Practices and Consumer Protection Law and unjust enrichment and civil conspiracy. It claims [...]

Pa. AG sues major drug makers, PBMs, alleges insulin market manipulation

HARRISBURG — Drug manufacturers and pharmaceutical middlemen conspired to manipulate insulin prices, artificially raising the cost of the life-saving medication by more than 1,000 percent, according to a lawsuit filed by Pennsylvania Attorney General Dave Sunday.

AG Sunday’s Antitrust Section Takes Action Against Insulin Makers, PBMs for Pricing Scheme, Resulting in Patients Paying More for Life-Saving Meds - PA Office of Attorney General

HARRISBURG — Attorney General Dave Sunday announced a lawsuit against several pharmaceutical companies and pharmacy benefit managers (PBMs) regarding collusion to manipulate insulin price markets, increasing out-of-pocket costs for Pennsylvanians. The Office of Attorney General’s Antitrust Section filed a complaint in the Commonwealth Court this week alleging violations of Pennsylvania’s Unfair Trade Practices and Consumer […]